FIELD: medicine.
SUBSTANCE: invention relates to a compound by the formula (2a), which can be applied as a pro-drug for inhibiting deacetylase UDP(uridine-5'-diphosphate)-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine (LpxC). In the formula (2a), X constitutes CH; Z constitutes 
and M+ constitutes a pharmaceutically acceptable monovalent cation selected from the group consisting of Li+, K+, Na+, NH4+, NH3+С(СН2ОН)3 or NH2+(CH2CH3)2. The invention also relates to a pharmaceutical composition for use as a pro-drug for inhibiting deacetylase UDP(uridine-5'-diphosphate)-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine (LpxC), containing an effective amount of said compound in a mixture with at least one pharmaceutically acceptable excipient, diluent or carrier, and to a method for treating an infection caused by gram-negative bacteria in a non-human animal in need thereof, including administering a therapeutically effective amount of said compound to a non-human animal in need thereof.
EFFECT: compound according to the disclosed invention can be used as a pro-drug for inhibiting deacetylase.
10 cl, 2 tbl, 32 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PRODUCING TWO 4-{[(2S)-2-{4-[5-CHLORO-2-(1H-1,2,3-TRIAZOL-1-YL)PHENYL]-5-METHOXY-2-OXOPYRIDIN-1(2H)-IL} BUTANOYL]AMINO}-2-FLUOROBENZAMIDE DERIVATIVES | 2019 |
|
RU2804663C2 |
| OXOPICOLINAMIDE DERIVATIVE, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2742771C2 |
| PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
| PYRAZINE COMPOUNDS AND THEIR USE | 2019 |
|
RU2809631C2 |
| NEW PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AND APPLICATION THEREOF | 2014 |
|
RU2621709C2 |
| BICYCLIC KETONES AND METHODS OF THEIR USE | 2018 |
|
RU2797922C2 |
| NEW DERIVATIVES OF IMIDAZO [4,5-C] QUINOLINES AND IMIDAZO [4,5-C] [1,5] NAPHTHYRIDINES AS LRRK2 INHIBITORS | 2016 |
|
RU2722149C1 |
| TRIAZOLE DERIVATIVES AND APPLICATION THEREOF IN NEUROLOGICAL DISEASES | 2011 |
|
RU2581504C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| CYCLOPENTANE COMPOUNDS | 2019 |
|
RU2794997C2 |
